Mirabella Financial Services LLP Amgen Inc Transaction History

Mirabella Financial Services LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $237,263 - $288,336	903 New	903 $282,000
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $180,012 - $203,075	704 Added 26.07%	3,404 $980,000
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $590,355 - $732,942	2,700 New	2,700 $725,000
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $225,790 - $275,200	1,000 New	1,000 $241,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $6.69 Million - $7.66 Million	-33,662 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $7.15 Million - $8.37 Million	33,662 New	33,662 $7.16 Million

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

Stay updated on Mirabella Financial Services LLP with notifications on news.